Cargando…

Circulating kidney injury molecule‐1 as a biomarker of renal parameters in diabetic kidney disease

AIMS/INTRODUCTION: Urinary kidney injury molecule‐1 (KIM‐1) has been associated with proximal tubular damage in human and animal studies. Although it has been recognized as a biomarker of acute kidney injury and chronic kidney disease, its significance in the serum remains unclear. Therefore, we exa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gohda, Tomohito, Kamei, Nozomu, Koshida, Takeo, Kubota, Mitsunobu, Tanaka, Kanako, Yamashita, Yoshinori, Adachi, Eri, Ichikawa, Saki, Murakoshi, Maki, Ueda, Seiji, Suzuki, Yusuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078097/ https://www.ncbi.nlm.nih.gov/pubmed/31483944 http://dx.doi.org/10.1111/jdi.13139

Ejemplares similares

Progranulin and Its Receptor Predict Kidney Function Decline in Patients With Type 2 Diabetes
por: Murakoshi, Maki, et al.
Publicado: (2022)

Aspartic acid supplementation ameliorates symptoms of diabetic kidney disease in mice
por: Ichikawa, Saki, et al.
Publicado: (2020)

The sodium–glucose cotransporter 2 inhibitor tofogliflozin prevents diabetic kidney disease progression in type 2 diabetic mice
por: Li, Zi, et al.
Publicado: (2020)

Fractional excretion of tumor necrosis factor receptor 1 and 2 in patients with type 2 diabetes and normal renal function
por: Gohda, Tomohito, et al.
Publicado: (2020)

Circulating Tumor Necrosis Factor Receptors: A Potential Biomarker for the Progression of Diabetic Kidney Disease
por: Murakoshi, Maki, et al.
Publicado: (2020)

Differential organ-specific inflammatory response to progranulin in high-fat diet-fed mice
por: Murakoshi, Maki, et al.
Publicado: (2021)

Association between circulating tumor necrosis factor-related biomarkers and estimated glomerular filtration rate in type 2 diabetes
por: Kamei, Nozomu, et al.
Publicado: (2018)

Development of an In-House EphA2 ELISA for Human Serum and Measurement of Circulating Levels of EphA2 in Hypertensive Patients with Renal Dysfunction
por: Murakoshi, Maki, et al.
Publicado: (2022)

Gut Microbiome and Microbiome-Derived Metabolites in Patients with End-Stage Kidney Disease
por: Koshida, Takeo, et al.
Publicado: (2023)

Sodium-Glucose Cotransporter-2 Inhibitors—Miracle Drugs for the Treatment of Chronic Kidney Disease Irrespective of the Diabetes Status: Lessons from the Dedicated Kidney Disease-Focused CREDENCE and DAPA-CKD Trials
por: Gohda, Tomohito, et al.
Publicado: (2022)

Circulating TNF Receptors 1 and 2 Predict Mortality in Patients with End-stage Renal Disease Undergoing Dialysis
por: Gohda, Tomohito, et al.
Publicado: (2017)

Circulating tumor necrosis factor receptors are associated with mortality and disease severity in COVID-19 patients
por: Gohda, Tomohito, et al.
Publicado: (2022)

Beneficial effects of tonsillectomy plus steroid pulse therapy on inflammatory and tubular markers in patients with IgA nephropathy
por: Maruyama, Shuntaro, et al.
Publicado: (2016)

Association Between Kidney Function Decline and Baseline TNFR Levels or Change Ratio in TNFR by Febuxostat Chiefly in Non-diabetic CKD Patients With Asymptomatic Hyperuricemia
por: Gohda, Tomohito, et al.
Publicado: (2021)

Effect of Exercise on Kidney Function, Oxidative Stress, and Inflammation in Type 2 Diabetic KK-A(y) Mice
por: Ishikawa, Yuji, et al.
Publicado: (2012)

Association of advanced glycation end products with sarcopenia and frailty in chronic kidney disease
por: Yabuuchi, Junko, et al.
Publicado: (2020)

Potential Targeting of Renal Fibrosis in Diabetic Kidney Disease Using MicroRNAs
por: Sakuma, Hiroko, et al.
Publicado: (2020)

Role of Mindin in Diabetic Nephropathy
por: Murakoshi, Maki, et al.
Publicado: (2011)

Continuous extracorporeal treatments in a dialysis patient with COVID-19
por: Nihei, Yoshihito, et al.
Publicado: (2020)

Efficacy and safety of pemafibrate in patients with chronic kidney disease: A retrospective study
por: Iwasaki, Masako, et al.
Publicado: (2023)

COVID-19-induced acute renal tubular injury associated with elevation of serum inflammatory cytokine
por: Fukao, Yusuke, et al.
Publicado: (2021)

Circulating TNF Receptors 1 and 2 Are Associated with the Severity of Renal Interstitial Fibrosis in IgA Nephropathy
por: Sonoda, Yuji, et al.
Publicado: (2015)

The Circulation in the Kidney
por: Smith, Bat.
Publicado: (1888)

Chronic intermittent hypoxia-mediated renal sympathetic nerve activation in hypertension and cardiovascular disease
por: Takahashi, Keiko, et al.
Publicado: (2018)

Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injury
por: Nakayama, Yosuke, et al.
Publicado: (2014)

A Rare Case with a Solitary Fibrous Tumour of the Colon and an Epithelioid Angiomyolipoma of the Kidney
por: Pham, Thong Quang, et al.
Publicado: (2013)

Association of Serum Zinc Level with severity of chronic kidney disease in diabetic patients: a cross-sectional study
por: Kubota, Mitsunobu, et al.
Publicado: (2022)

Recent Advances of Acute Kidney Injury in Hematopoietic Cell Transplantation
por: Miyata, Masahiro, et al.
Publicado: (2022)

Clinical Use and Treatment Mechanism of Molecular Hydrogen in the Treatment of Various Kidney Diseases including Diabetic Kidney Disease
por: Hirano, Shin-ichi, et al.
Publicado: (2023)

Certain Drugs on the Circulation of the Kidneys
por: Phillips, Charles D. F.
Publicado: (1887)

Circulating Adipocytokines and Chronic Kidney Disease
por: Mills, Katherine T., et al.
Publicado: (2013)

A Case of Rapid Progressive Kidney Dysfunction with Severely Calcified Stenotic Aorta
por: Harada, Makoto, et al.
Publicado: (2018)

Current Status of Adverse Event Profile of Cyclosporine in Kidney, Stem Cell, and Heart Transplantations Using the Japanese Pharmacovigilance Database
por: Niinomi, Iku, et al.
Publicado: (2022)

Urate Transporter 1 Can Be a Therapeutic Target Molecule for Chronic Kidney Disease and Diabetic Kidney Disease: A Retrospective Longitudinal Study
por: Yanai, Hidekatsu, et al.
Publicado: (2023)

Circulating Endothelial Cells and Chronic Kidney Disease
por: Zhang, Kunying, et al.
Publicado: (2014)

Circulating miRNAs as biomarkers of kidney disease
por: Hüttenhofer, Alexander, et al.
Publicado: (2017)

Pathogenesis and Novel Treatment from the Mouse Model of Type 2 Diabetic Nephropathy
por: Furukawa, Masako, et al.
Publicado: (2013)

Molecular pathways that drive diabetic kidney disease
por: Mohandes, Samer, et al.
Publicado: (2023)

Using circulating O-sulfotyrosine in the differential diagnosis of acute kidney injury and chronic kidney disease
por: Chen, Shuai, et al.
Publicado: (2021)

Risk factors for cisplatin-induced acute kidney injury: A pilot study on the usefulness of genetic variants for predicting nephrotoxicity in clinical practice
por: Oda, Hiroyasu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b466nj8jhn16ppnmioba94itd5